| 701308 |
FRONTIERS IN ONCOLOGY |
Low Expression of ADCY4 Predicts Worse Survival of Lung Squamous Cell Carcinoma Based on Integrated Analysis and Immunohistochemical Verification |
2021-06-10 |
10.3389/fonc.2021.637733 |
Liu Zhicong, Ru Lixin, Ma Zhenchao |
| 701307 |
FRONTIERS IN ONCOLOGY |
Ipriflavone Suppresses Growth of Esophageal Squamous Cell Carcinoma Through Inhibiting mTOR In Vitro and In Vivo |
2021-06-10 |
10.3389/fonc.2021.648809 |
Shi Xiaodan, Zhang Yuanyuan, Xie Xiaomeng, Pang Mengjun, Laster Kyle, Li Jian, Ma Xinli, Liu Kangdong, Dong Zigang, Kim Dong Joon |
| 701306 |
FRONTIERS IN ONCOLOGY |
Expression and Prognostic Significance of PD-L2 in Diffuse Large B-Cell Lymphoma |
2021-06-10 |
10.3389/fonc.2021.664032 |
Gu Qianhui, Li Jing, Chen Zhuolin, Zhang Jie, Shen Hui, Miao Xiaobing, Zhou Ying, Xu Xiaohong, He Song |
| 701305 |
FRONTIERS IN ONCOLOGY |
Insights Into the Function and Clinical Application of HDAC5 in Cancer Management |
2021-06-10 |
10.3389/fonc.2021.661620 |
Yang Jun, Gong Chaoju, Ke Qinjian, Fang Zejun, Chen Xiaowen, Ye Ming, Xu Xi |
| 701304 |
FRONTIERS IN ONCOLOGY |
PHGDH Is Upregulated at Translational Level and Implicated in Platin-Resistant in Ovarian Cancer Cells |
2021-06-10 |
10.3389/fonc.2021.643129 |
Bi Fangfang, An Yuanyuan, Sun Tianshui, You Yue, Yang Qing |
| 701303 |
FRONTIERS IN ONCOLOGY |
Evaluation of Epigallocatechin-3-Gallate as a Radioprotective Agent During Radiotherapy of Lung Cancer Patients: A 5-Year Survival Analysis of a Phase 2 Study |
2021-06-10 |
10.3389/fonc.2021.686950 |
Zhu Wanqi, Zhao Yalan, Zhang Shuyu, Li Xiaolin, Xing Ligang, Zhao Hanxi, Yu Jinming |
| 701302 |
FRONTIERS IN ONCOLOGY |
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy |
2021-06-10 |
10.3389/fonc.2021.673276 |
Marofi Faroogh, Al-Awad Alaa S., Sulaiman Rahman Heshu, Markov Alexander, Abdelbasset Walid Kamal, Ivanovna Enina Yulianna, Mahmoodi Mahnaz, Hassanzadeh Ali, Yazdanifar Mahboubeh, Stanley Chartrand Max, Jarahian Mostafa |
| 701301 |
FRONTIERS IN ONCOLOGY |
High LET-Like Radiation Tracks at the Distal Side of Accelerated Proton Bragg Peak |
2021-06-10 |
10.3389/fonc.2021.690042 |
Horendeck Dakota, Walsh Kade D., Hirakawa Hirokazu, Fujimori Akira, Kitamura Hisashi, Kato Takamitsu A. |
| 701300 |
FRONTIERS IN ONCOLOGY |
DDX60 Is Associated With Glioma Malignancy and Serves as a Potential Immunotherapy Biomarker |
2021-06-10 |
10.3389/fonc.2021.665360 |
Zhang Jingwen, Fu Minjie, Zhang Mengli, Zhang Jinsen, Du Zunguo, Zhang Hongyi, Hua Wei, Mao Ying |
| 701299 |
FRONTIERS IN ONCOLOGY |
Immunonutritive Scoring in Patients With Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Prognostic Nutritional Index or Controlling Nutritional Status Score? |
2021-06-10 |
10.3389/fonc.2021.696183 |
Müller Lukas, Hahn Felix, Mähringer-Kunz Aline, Stoehr Fabian, Gairing Simon J., Foerster Friedrich, Weinmann Arndt, Galle Peter R., Mittler Jens, Pinto dos Santos Daniel, Pitton Michael B., Düber Christoph, Kloeckner Roman |
